FdaApplication
ANDA 205429
Identifiers
- fda_app_no: ANDA205429
Properties
| Property | Value |
|---|---|
| applicant_name | ALVOGEN INC |
| application_type | ANDA |
| approval_date | 2016-01-07 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPSONE | DAPSONE | 25MG | TABLET;ORAL |
| DAPSONE | DAPSONE | 100MG | TABLET;ORAL |
2 products